End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56,600 KRW | -1.91% | -4.87% | -21.39% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Sales 2024 * | 242B 177M | Sales 2025 * | 325B 238M | Capitalization | 4,348B 3.18B |
---|---|---|---|---|---|
Net income 2024 * | -37B -27.08M | Net income 2025 * | -16B -11.71M | EV / Sales 2024 * | 12.8 x |
Net cash position 2024 * | 1,242B 909M | Net cash position 2025 * | 663B 486M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
-116
x | P/E ratio 2025 * |
-271
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.48% |
1 day | -1.91% | ||
1 week | -4.87% | ||
Current month | -3.41% | ||
1 month | -1.57% | ||
3 months | -11.42% | ||
6 months | -16.02% | ||
Current year | -21.39% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -5.30% | ||
0.04% | 15 M€ | +19.89% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 56,600 | -1.91% | 98,341 |
24-05-23 | 57,700 | -0.69% | 60,247 |
24-05-22 | 58,100 | +0.35% | 52,731 |
24-05-21 | 57,900 | -2.85% | 85,059 |
24-05-20 | 59,600 | +0.17% | 54,720 |
End-of-day quote Korea S.E., May 23, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.39% | 3.19B | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- A302440 Stock